Cas:957493-98-0 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea manufacturer & supplier

Chemical Name:1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea

CAS.NO:957493-98-0

Synonyms:1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea

Molecular Formula:C₃₃H₃₃N₅O₃

Molecular Weight:547.64682

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea Use and application,1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea technical grade,usp/ep/jp grade.

Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea manufacturer The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea supplier ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea vendor There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 1-(3′,6′-bis(ethylaMino)-2′,7′-diMethyl-3- oxospiro[isoindoline-1,9′-xanthene]-2-yl)-3- phenylurea factory For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.”